Dr Tahera Bhojani-Lynch

GMC Registered: 3323786

MBChB, MRCOphth, CertLRS, MBCAM, DipClinDerm, DipCS

Book Consultation

Cheshire

Medispa London

0808 189 3558

Over 20 years of aesthetic medicine experience and over 35 years of clinical practice, specialising in botulinum toxin and hyaluronic acid
First female British graduate to perform LASIK surgery in the UK, with more than 12,000 corneal laser surgeries performed
International Key Opinion Leader and Global Expert for Teoxane, with active roles in international clinical trials and post-marketing safety registries
Available for a free consultation at Dr Nyla Medispa London Mayfair

About Dr Tahera Bhojani-Lynch

Dr Tahera Bhojani-Lynch is a GMC-registered aesthetic doctor, international award-winning clinician, and laser eye surgeon who has practised across both ophthalmology and aesthetic medicine for over three decades. A Member of the Royal College of Ophthalmologists, she was the first female British graduate to perform LASIK surgery in the United Kingdom and is a certified laser refractive surgeon with more than 12,000 corneal laser procedures performed.

Dr Tahera holds postgraduate diplomas in Clinical Dermatology, Cosmetic Science, Pharmaceutical Medicine, and Laser Skin Therapy, alongside full membership of the British College of Aesthetic Medicine, where she also sits on the Ethics Committee. She is a faculty member of the International Association for the Prevention of Complications in Aesthetic Medicine, a GMC Medical Appraiser, and an accredited mentor for refugee doctors working in the NHS through the Midlands Mentoring Scheme. Her clinical research and practice in botulinum toxin and hyaluronic acid spans over 20 years.

As an International Key Opinion Leader, Global Expert and Clinical Trial Medical Monitor for Teoxane Laboratories in Geneva, Dr Tahera trains aesthetic practitioners across Europe, Asia-Pacific, the Middle East and South America. She is fluent in English and Gujarati, with conversational proficiency in Urdu and Hindi.

Medical Qualifications and Registration

MBChB, University of Aberdeen Medical School, 1989
MRCOphth, Royal College of Ophthalmologists, 1995
Postgraduate Diploma in Pharmaceutical Medicine, University of Wales, 2002
Higher BTech in Laser Skin Applications, Loughborough College, 2004
Higher Certificate in Cosmetic Science, De Montfort University, 2007
DipCS, Diploma in Cosmetic Science, Society of Cosmetic Scientists, 2007
CertLRS, Certificate in Laser Refractive Surgery, Royal College of Ophthalmologists, 2009
DipClinDerm, Postgraduate Diploma in Clinical Dermatology, Queen Mary University and Barts London, 2022
ICH GCP E6 Clinical Trials Certification, The Global Health Network, 2022
Surgical Accreditation in Blepharoplasty, EIMEC Barcelona, 2023
Advanced Life Support, Resuscitation Council UK
MBCAM, Member of the British College of Aesthetic Medicine
Faculty Member, International Association for the Prevention of Complications in Aesthetic Medicine
GMC Registration: 3323786, fully licensed to practise in the United Kingdom

Dr Tahera Bhojani-Lynch is registered with the General Medical Council (GMC), Registration No. 3323786, verifiable on the GMC public register.

Professional Appointments and Industry Roles

GMC Medical Appraiser for BCAM and MEDSU, with over 100 appraisals completed since 2020
Mentor for refugee doctors working in the NHS, Midlands Mentoring Scheme, NHS England, since 2021
Faculty Member and Senior Complications Consultant, International Association for the Prevention of Complications in Aesthetic Medicine
International Key Opinion Leader, Global Expert and Clinical Trial Medical Monitor, Teoxane Laboratories, Geneva
Independent Training and Safety Consultant for leading pharmaceutical companies including Sinclair, Teoxane, Merz, Galderma and Allergan
Complications Management Consultant and Aesthetic Doctor, Dr Nyla Medispa
First female British LASIK eye surgeon, Optimax Specialist Eye Laser Clinics

Professional Memberships

Full Member, British College of Aesthetic Medicine, Ethics Committee
Qualified Member, Royal College of Ophthalmologists
Qualified Member and Councillor, British Society of Refractive Surgeons
Qualified Member, European Society of Refractive Surgeons
Member, British Medical Association
Faculty Member, International Association for the Prevention of Complications in Aesthetic Medicine

Clinical Experience and Specialisms

Dr Tahera is particularly renowned for her work in periocular rejuvenation, delivering highly precise injectable treatments in one of the most technically demanding areas of the face. Her approach is evidence-based, with a strong focus on patient safety and natural outcomes, particularly in advanced treatments such as Tear Trough Fillers and Dermal Fillers, where precision and anatomical expertise are essential.

She is credited with coining the term “hot hollow” when describing the most aesthetically attractive shape of the male face, and she speaks internationally on the anatomical differences that distinguish male and female facial aesthetics.

As a recognised Key Opinion Leader, Dr Tahera trains aesthetic practitioners internationally and contributes to advancing clinical standards in aesthetic medicine through education and mentorship.

Clinical Research and Trials

Dr Tahera has served as Principal Investigator on multiple international clinical trials, contributing primary evidence to the safety and longevity profile of leading injectable products.

Principal Investigator, International Multicentre Post-Marketing Safety and Longevity Study for PerfectHA Subskin, Sinclair Pharma, 2023 to present
Principal Investigator, International Multicentre Post-Marketing Safety and Longevity Registry for Hyaluronic Acid Dermal Fillers, Teoxane Geneva, 2019 to 2022
Principal Investigator, International Multicentre Phase III Clinical Trial for the Treatment of Submental Fat, Bayer, Intendis and Parexel, 2010 to 2012
Principal Investigator, Latanoprost International Study Group, Pharmacia and Upjohn, supporting the Marketing Authorisation for Xalatan

Dr Tahera is also ICH GCP E6 certified for clinical trial conduct.

Research and Publications

Dr Tahera is a published author in peer-reviewed journals and a regular contributor to clinical and trade publications. Her landmark paper on hyaluronic acid filler safety was awarded the Most Read Paper in the History of Plastic and Reconstructive Surgery Global Open in 2023.

Peer-Reviewed Publications:

Bhojani-Lynch T, Berros P, Snozzi P. Optimizing Infraorbital Hollows With Hyaluronic Acid Fillers. Aesthetic Surgery Journal Open Forum, 2025.
Bhojani-Lynch T et al. A Prospective Observational Registry Study to Evaluate the Effectiveness and Safety of Hyaluronic Acid Fillers in Routine Practice. Clinical, Cosmetic and Investigational Dermatology, 2021.
Bhojani-Lynch T. Late Onset Inflammatory Response to Hyaluronic Acid Dermal Fillers. Plastic and Reconstructive Surgery Global Open, November 2017, Vol 5, Issue 12. Awarded Most Read Paper in the History of PRS Global Open in 2023 and International Best European Paper in 2018.
Azuara-Blanco A, Bhojani T et al. Tono-pen determination of intraocular pressure in patients with band keratopathy or glued cornea. British Journal of Ophthalmology, June 1998, Vol 82, Issue 6.

Trade and Clinical Publications:

Breaking the Stigma for Male Treatments. Aesthetics Journal, 2021.
The Last Word: Practising Post Covid. Aesthetics Journal, 2020.
The Last Word: Challenging “The Facts”. Aesthetics Journal, 2020.
Animal Products and Patient Perceptions. Aesthetics Journal, 2018.
Attracting and Retaining Male Patients. Aesthetics Journal, 2018.
Treating the Male Mid Face. Aesthetics Journal, 2017.
The Hot Hollow: Identifying Traits that Distinguish Male Attractiveness. Aesthetics Journal, 2017.
A Masterclass in Peri-Orbital Rejuvenation. Teoxane Times, Autumn Winter 2016.

Clinical Research Contributions:

Teoxane Eyelight Study: Redensity 2 for Periorbital Rejuvenation

Awards and Recognition

Most Read Paper in the History of Plastic and Reconstructive Surgery Global Open, 2023, for Late Onset Inflammatory Response to Hyaluronic Acid Dermal Fillers
Diamond National Aesthetic Awards, 2021, Runner Up, Best Facial Transformation Treatment
International Best European Paper Winner, 2018, for Late Onset Inflammatory Response to Hyaluronic Acid Dermal Fillers

International Speaking and Training

Dr Tahera is an invited international speaker and live demonstrator at the world’s leading aesthetic medicine congresses, with over 30 keynote and faculty appearances across Europe, Asia-Pacific, the Middle East and the Americas. Recent appointments include:

Teoxane 20th Anniversary Congress, Barcelona, 2023, speaker and moderator
International Master Course on Aging Science (IMCAS), Paris, multiple years, invited speaker and live demonstrator
Aesthetic and Anti-Aging Medicine World Congress (AMWC), Monaco, invited speaker and live demonstrator
Indonesian Aesthetic Meeting, Bali, 2023, speaker and moderator
Teoxane Australian Roadshow, Sydney, invited speaker
British College of Aesthetic Medicine Annual Scientific Conference, multiple years
International Association for the Prevention of Complications in Aesthetic Medicine (IAPCAM) Symposium, faculty member and guest speaker
Teoxane APAC Tour, Hong Kong, Seoul, Sydney, Perth and New Zealand, trainer and live demonstrator

Media Recognition

Dr Tahera has been featured in The Times, Metro, the National Institute of Health, Oxford Academics, and the Aesthetics Journal.

Frequently Asked Questions

Is Dr Tahera Bhojani-Lynch GMC registered?

Yes. Dr Tahera Bhojani-Lynch is fully registered with the General Medical Council. Her GMC number is 3323786. Registration can be verified at gmc-uk.org.

What qualifications does Dr Tahera Bhojani-Lynch hold?

Dr Tahera holds an MBChB from the University of Aberdeen, MRCOphth, CertLRS, DipClinDerm, DipCS, and MBCAM. She has over 25 years of clinical experience with botulinum toxin and hyaluronic acid.

What does Dr Tahera Bhojani-Lynch specialise in?

Dr Tahera specialises in periocular rejuvenation and precise injectable treatments around the eye area. She also has extensive expertise in non-surgical facial rejuvenation, laser treatments, and aesthetic medicine across multiple regions globally.

Where does Dr Tahera Bhojani-Lynch practise?

Dr Tahera sees patients at London Mayfair (32 Dover Street, W1S 4NE), and Cheshire Alderley Edge (Castlerock House, Wilmslow Road, SK9 7QL). To book a consultation, please contact the clinic.

Has Dr Tahera Bhojani-Lynch published peer-reviewed research?

Yes. Dr Tahera is a published author in peer-reviewed journals including Aesthetic Surgery Journal Open Forum, Plastic and Reconstructive Surgery Global Open, Clinical Cosmetic and Investigational Dermatology, and the British Journal of Ophthalmology. Her paper on hyaluronic acid filler safety was awarded Most Read Paper in the History of PRS Global Open in 2023.

Is Dr Tahera Bhojani-Lynch involved in clinical trials?

Yes. Dr Tahera has served as Principal Investigator on multiple international clinical trials for leading aesthetic and pharmaceutical brands including Sinclair, Teoxane and Bayer. She is ICH GCP E6 certified for clinical trial conduct.